Pluripotent stem cell-derived neural progenitor cells can be used to model effects of IL-6 on human neurodevelopment

• Published in: Disease models & mechanisms 2023-11, Vol.16 (11)
• Main Authors: Sarieva, Kseniia, Hildebrand, Felix, Kagermeier, Theresa, Yentür, Zeynep, Becker, Katharina, Mayer, Simone
• Format: Article
• Language: English
• Subjects: induced pluripotent stem cells; interleukin-6; maternal immune activation; neural progenitor cells; Resource
• ISSN: 1754-8403; 1754-8411
• DOI: 10.1242/dmm.050306

Maternal immune activation (MIA) increases the risks for neurodevelopmental disorders in offspring through inflammatory cytokines, including interleukin-6 (IL-6). We therefore aimed to establish a human two-dimensional (2D) in vitro neural model to investigate the effects of IL-6 exposure on neurodevelopment. IL-6 signal transduction requires two receptors: interleukin-6 signal transducer (IL6ST) and interleukin-6 receptor (IL6R). Prenatally, neural cells lack IL6R, and hence cannot elicit cis IL-6 signaling, but IL6R can be provided by microglia in trans. We demonstrate here that an immortalized human neural progenitor cell (NPC) line, ReNCell CX, expresses IL6ST and elicits both cis and trans IL-6 signaling, limiting its use as a model of MIA. In contrast, induced pluripotent stem cell (iPSC)-derived NPCs only activate the IL-6 cascade in trans. Activation of the trans IL-6 cascade did not result in increased proliferation of iPSC-derived NPCs or ReNCell CX, as has been demonstrated in animal models. iPSC-derived NPCs upregulated NR2F1 expression in response to IL-6 signaling in line with analogous experiments in organoids. Thus, iPSC-derived NPCs can be used to model gene expression changes in response to MIA in 2D cultures.